当期报告
First Wave BioPharma(FWBI)03-19 04:45
$First Wave BioPharma(FWBI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-035598 Act: 34 Size: 230 KB 网页链接
简介:First Wave BioPharma, Inc.在美国特拉华州成立于2014年1月30日。该公司是一家临床阶段的生物制药公司,从事的是为胃肠功能紊乱患者的治疗,研究和开发非系统性生物制剂。
今开:2.73 | 昨收:2.68 |
最高:2.73 | 最低:2.65 |
涨停价: | 跌停价: |
总市值:5399788 |
First Wave BioPharma(FWBI)03-19 04:45
$First Wave BioPharma(FWBI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-035598 Act: 34 Size: 230 KB 网页链接
First Wave BioPharma(FWBI)03-20 04:15
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-036143 Size: 5 KB 网页链接
First Wave BioPharma(FWBI)03-16 06:15
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010163 Size: 9 KB 网页链接
First Wave BioPharma(FWBI)02-15 03:55
$First Wave BioPharma(FWBI)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001264 Act: 34 Size: 90 KB 网页链接
First Wave BioPharma(FWBI)03-14 18:15
$First Wave BioPharma(FWBI)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.02, 3.03, 5.02, 5.03, 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-034161 Act: 34 Size: 2 MB 网页链接
First Wave BioPharma(FWBI)03-16 06:05
$First Wave BioPharma(FWBI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-24-010161 Size: 11 KB 网页链接
First Wave BioPharma(FWBI)03-05 06:35
$First Wave BioPharma(FWBI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-030561 Act: 33 Size: 412 KB 网页链接
First Wave BioPharma(FWBI)03-19 04:35
$First Wave BioPharma(FWBI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-035586 Act: 34 Size: 37 KB 网页链接
First Wave BioPharma(FWBI)03-23 05:05
$First Wave BioPharma(FWBI)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-037932 Act: 34 Size: 202 KB 网页链接
First Wave BioPharma(FWBI)03-20 04:15
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-036138 Size: 5 KB 网页链接
chuminhua2023-09-15 10:56
9/14,First Wave BioPharma $First Wave BioPharma(FWBI)$ 宣布与赛诺菲达成协议,获得选择性 5-HT4 受体部分激动剂 Capeserod 的许可,该公司股价周四上涨 82%。 通过独家全球许可协议,First Wave 将重新利用和开发该药物用于胃肠道 (GI) 适应症。
根据交易条款,赛诺菲将获得 50 万美元的...查看全文
产业链观察2023-07-13 20:12
#药闻简讯# 2023 年 7 月 13 日,专注于开发胃肠道(GI)疾病的非系统性靶向疗法处于临床阶段的生物制药公司$First Wave BioPharma(FWBI)$ 今天宣布公司的2期SPAN临床试验取得了初步结果,该试验研究了一种增强型阿杜立普酶肠道微颗粒给药配方,用于治疗囊性纤维化(CF)患者的胰腺外分泌功能不全...查看全文
不入流资讯2023-07-13 19:42
$First Wave BioPharma(FWBI)$ First Wave BioPharma fell more than 16% in premarket trading after Co. said a Phase 2 study of an enhanced formulation of its adrulipase drug candidate likely missed its primary efficacy endpoint. 网页链接查看全文
牛唐2023-06-14 15:59
医药板块速评(2022.06.13)
1、医美赛道集体回调,哪些标的有配置机会?
2、$First Wave BioPharma(FWBI)$ 单日爆拉100%+,谁有潜力成为下一个?
3、$FANG+ETN-MicroSectors(FNGS)、$谷歌A(GOOGL)$ 、$Rivian Automotive(RIVN)$ 期权异动,后续走势如何看?查看全文
不入流资讯2023-06-13 21:51
$First Wave BioPharma(FWBI)$ The First Wave BioPharma Inc stock soared 156% after it reached the enrollment target for its Phase 2 SPAN clinical trial. #AI_Mover# AInvestPro查看全文
牛唐2023-01-25 22:43
$First Wave BioPharma(FWBI)$ 两周60%+的收益。$拼多多(PDD)$ $蔚来(NIO)$查看全文
心地宽惠泽长2021-09-30 21:49
$First Wave BioPharma(FWBI)$ 这是要再次1元以下的节奏吗?查看全文
来源:格隆汇 生物制药公司First Wave BioPharma (FWBI.US)暴涨117.83%,报0.94美元。First Wave宣布与法国医药巨头赛诺菲达成Capeserod的全球独家许可协议,该药物有望用于治疗胃肠道疾病(GI)。 责任编辑:郭明煜 网页链接
来源:格隆汇 格隆汇6月29日丨First Wave BioPharma(FWBI.US)盘前涨5.81%,报1.64美元。公司今日宣布,在研究增强型阿杜利普酶肠道微丸给药配方的SPAN 2期临床试验中,最后一名患者已经服药,用于治疗囊性纤维... 网页链接
First Wave BioPharma(FWBI)盘前大涨30%,报4.16美元。 First Wave BioPharma宣布,一篇题为“Adrulipase肠内保护喷雾干燥分散制剂的配方开发”的摘要已被2022年美国医学科学家协会年会接受。会议将于10月16日至19日在波士顿会展中心举行。... 网页链接
生物制药公司First Wave BioPharma涨31.28%,此前研究称其产品可用于治疗新冠肺炎相关胃肠道感染。 网页链接
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043154 Size: 5 KB 网页链接
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043156 Size: 5 KB 网页链接
$First Wave BioPharma(FWBI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000364 Act: 34 Size: 11 MB 网页链接
$First Wave BioPharma(FWBI)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-037932 Act: 34 Size: 202 KB 网页链接
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-036138 Size: 5 KB 网页链接
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-036143 Size: 5 KB 网页链接
$First Wave BioPharma(FWBI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-035598 Act: 34 Size: 230 KB 网页链接
$First Wave BioPharma(FWBI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-035586 Act: 34 Size: 37 KB 网页链接
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010162 Size: 12 KB 网页链接
$First Wave BioPharma(FWBI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010163 Size: 9 KB 网页链接